EMA shortages Shortage resolved Medicine shortages
Cinryze — supply shortage (shortage resolved)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Cinryze
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): C1 inhibitor (human)
- Therapeutic area: Angioedemas, Hereditary
- Pharmaceutical forms affected: Powder and solvent for intravenous injection
- Strengths affected: 500 IU
- Last updated: 25/06/2020
Measures and alternatives
- Availability of alternatives: Yes
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗